MAPAX
Price
$31.28
Change
-$0.05 (-0.16%)
Updated
Aug 15 closing price
Net Assets
945.93M
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

MAPAX vs VVIAX

Header iconMAPAX vs VVIAX Comparison
Open Charts MAPAX vs VVIAXBanner chart's image
NYLI WMC Value
Price$31.28
Change-$0.05 (-0.16%)
VolumeN/A
Net Assets945.93M
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
MAPAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MAPAX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAPAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. MAPAX (946M). VVIAX pays higher dividends than MAPAX: VVIAX (2.18) vs MAPAX (1.39). MAPAX was incepted earlier than VVIAX: MAPAX (26 years) vs VVIAX (25 years). MAPAX (1.02) is less costly to investors than VVIAX (0.05). MAPAX is a more actively managed with annual turnover of: 38.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than MAPAX: VVIAX (3000) vs MAPAX (15000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. MAPAX (4.70). VVIAX return over 5 years is better than : 68.54 vs. MAPAX (-19.42).
MAPAXVVIAXMAPAX / VVIAX
Total Expense Ratio1.020.052,040%
Annual Report Gross Expense Ratio1.020.052,040%
Fund Existence26 years25 years-
Gain YTD6.7216.517103%
Front Load6%N/A-
Min. Initial Investment150003000500%
Min. Initial Investment IRAN/AN/A-
Net Assets946M196B0%
Annual Yield % from dividends1.392.1864%
Returns for 1 year4.707.9160%
Returns for 3 years10.0925.9339%
Returns for 5 years-19.4268.54-28%
Returns for 10 years-25.19114.61-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp